QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Improved Synthesis of 6-Chloro-5-methylpyridin-2-amine: A Key Intermediate for Making Lumacaftor 期刊论文 ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2020, 卷号: 24, 期号: 6, 页码: 1175-1179 作者:  Zhang, Junchi;  Zhu, Fuqiang;  Tian, Guanghui;  Jiang, Xiangrui;  Shen, Jingshan 收藏  |  浏览/下载：21/0  |  提交时间：2020/12/24 6-chloro-5-methylpyridin-2-amine  lumacaftor  methylation  safe   Efficacy and Safety of CFTR Corrector and Potentiator Combination Therapy in Patients with Cystic Fibrosis for the F508del-CFTR Homozygous Mutation: A Systematic Review and Meta-analysis. 期刊论文 Advances in therapy, 2018 作者:  Wu Hong-Xia;  Zhu Min;  Xiong Xiao-Feng;  Wei Jia;  Zhuo Kai-Quan 收藏  |  浏览/下载：4/0  |  提交时间：2019/02/25 Cystic  fibrosis  Cystic  fibrosis  transmembrane  conductance  regulator  Ivacaftor  Lumacaftor  Tezacaftor   Efficacy and Safety of CFTR Corrector and Potentiator Combination Therapy in Patients with Cystic Fibrosis for the F508del-CFTR Homozygous Mutation: A Systematic Review and Meta-analysis. 期刊论文 Advances in therapy, 2018 作者:  Wu Hong-Xia;  Zhu Min;  Xiong Xiao-Feng;  Wei Jia;  Zhuo Kai-Quan 收藏  |  浏览/下载：4/0  |  提交时间：2019/02/25 Cystic  fibrosis  Cystic  fibrosis  transmembrane  conductance  regulator  Ivacaftor  Lumacaftor  Tezacaftor   F508del-cystic fibrosis transmembrane regulator correctors for treatment of cystic fibrosis: a patent review 期刊论文 Expert Opinion on Therapeutic Patents, 2015, 卷号: Vol.25 No.9, 页码: 991-1002 作者:  Hong Yang;  Tonghui Ma 收藏  |  浏览/下载：10/0  |  提交时间：2019/02/27 cystic  fibrosis  cystic  fibrosis  transmembrane  regulator  cystic  fibrosis  transmembrane  regulator  corrector  cystic  fibrosis  transmembrane  regulator  modulator  cystic  fibrosis  transmembrane  regulator  potentiator  ivacaftor  lumacaftor